Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joseph R. Martinez"'
Publikováno v:
Journal of Benefit-Cost Analysis. 13:166-181
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee7bd9f15f5af4bda3ea5c88b00cad48
https://doi.org/10.1017/bca.2022.12
https://doi.org/10.1017/bca.2022.12
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b787296ded3c169393c8d67dc3191f66
https://doi.org/10.2139/ssrn.4461622
https://doi.org/10.2139/ssrn.4461622
Publikováno v:
Value in Health. 24:1476-1483
Objectives Cost-effectiveness analysis of branded pharmaceuticals presumes that both cost (or price) and marginal effectiveness levels are exogenous. This assumption underlies most judgments of the cost-effectiveness of specific drugs. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41cc0683e649637e578d2243282711c
https://doi.org/10.1016/j.jval.2021.04.1289
https://doi.org/10.1016/j.jval.2021.04.1289
Autor:
Amol S. Navathe, Joseph R. Martinez, Eric Z. Shan, Claire T. Dinh, Jack J Huang, Joshua M. Liao, Erin Q Huang
Publikováno v:
Healthc (Amst)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1882c4389fe927207e26d6c192079b3a
https://doi.org/10.1016/j.hjdsi.2019.04.002
https://doi.org/10.1016/j.hjdsi.2019.04.002
Autor:
Joseph R. Martinez, Deborah S. Cousins, Yueming Zhao, Amol S. Navathe, Jingsan Zhu, Atul Gupta, Joshua M. Liao
Publikováno v:
JAMA
Medicare's Bundled Payments for Care Improvement (BPCI) program, which ran from 2013 to 2018, was an important experiment in physician-focused alternative payment models. However, little is known about whether the program was associated with better q
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee30cc80f0273e504e2ac012823f531
https://doi.org/10.1001/jama.2021.10046
https://doi.org/10.1001/jama.2021.10046
Publikováno v:
BMJ Qual Saf
BackgroundThe Hospital Readmissions Reduction Program (HRRP) initially penalised hospitals for excess readmission within 30 days of discharge for acute myocardial infarction (AMI), congestive heart failure (CHF) or pneumonia (PNA) and was expanded in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea832f167a0c8af08450e71a37e339f
https://pubmed.ncbi.nlm.nih.gov/32694145
https://pubmed.ncbi.nlm.nih.gov/32694145
Autor:
Justin E. Bekelman, Ezekiel J. Emanuel, Qian Huang, Ravi B. Parikh, Amol S. Navathe, Joseph R. Martinez
Publikováno v:
J Oncol Pract
PURPOSE: The Oncology Care Model (OCM) is Medicare’s first bundled payment program for patients with cancer. We examined baseline characteristics of OCM physician participants and markets with high OCM physician participation to inform generalizabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f51cae06efb7010cf64a3016b52f0fcf
https://europepmc.org/articles/PMC7846066/
https://europepmc.org/articles/PMC7846066/
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 12
Background: The Hospital Readmission Reduction Program (HRRP) was enacted in March 2010 and imposed financial penalties beginning in October 2012 for hospitals with higher-than-expected 30-day readmissions for acute myocardial infarction (AMI), conge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e09bf68b522022378da2396f6e6fa809
https://doi.org/10.1161/hcq.12.suppl_1.159
https://doi.org/10.1161/hcq.12.suppl_1.159
Autor:
Daniel Polsky, Robin Wang, Yash Shah, Amol S. Navathe, Zoe Lyon, Qian Huang, Joseph R. Martinez, Ezekiel J. Emanuel, Joshua M. Liao, Jingsan Zhu, Josh Rolnick
Publikováno v:
Health Aff (Millwood)
As policy makers debate engaging hospitals in voluntary or mandatory bundled payment mechanisms, they lack evidence about how participants in existing programs compare. We analyzed data from Medicare and the American Hospital Association Annual Surve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d968804a4523469e1ef035d46670c91c
https://pubmed.ncbi.nlm.nih.gov/29863929
https://pubmed.ncbi.nlm.nih.gov/29863929
Publikováno v:
Journal of Hospital Management and Health Policy. 3:16-16
Background: The US spends significantly more per capita on healthcare than other developed countries. The Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) has created various alternative payment models (APMs) that use financi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1d920c5b33ad35a414a77a727464905
https://doi.org/10.21037/jhmhp.2019.06.03
https://doi.org/10.21037/jhmhp.2019.06.03